Microscopic Hematuria (2025): Difference between revisions

No edit summary
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:
See [https://www.auanet.org/documents/Guidelines/PDF/2025%20Guidelines/Microhematuria%20Diagnostic%20Algorithm%20%284%292.4.25.pdf '''Algorithm associated with this Guideline''']
See [https://www.auanet.org/documents/Guidelines/PDF/2025%20Guidelines/Microhematuria%20Diagnostic%20Algorithm%20%284%292.4.25.pdf '''Algorithm associated with this Guideline''']


See [[Microscopic Hematuria (2020 AUA Guidelines)|AUA Microscopic Hematuria Guidelines (2020)]]
See [[Microscopic Hematuria (2020 AUA Guidelines)|'''AUA Microscopic Hematuria Guidelines (2020)''']]


'''See [[CUA: Asymptomatic Microscopic Hematuria (2008)|CUA Asymptomatic Microscopic Hematuria Guidelines 2008]]'''
'''See [[CUA: Asymptomatic Microscopic Hematuria (2008)|CUA Asymptomatic Microscopic Hematuria Guidelines 2008]]'''
Line 243: Line 243:
==== Special Scenarios ====
==== Special Scenarios ====
* '''In patients with persistent or recurrent MH previously evaluated with renal US, consider additional imaging of the urinary tract'''
* '''In patients with persistent or recurrent MH previously evaluated with renal US, consider additional imaging of the urinary tract'''
* '''In patients with MH who have a family history of renal cell carcinoma or a known genetic renal tumor syndrome, upper tract imaging should be performed regardless of risk category.'''
* '''In patients with MH who have a family history of renal cell carcinoma, a known genetic renal tumor syndrome, or a personal or family history of (or suspicious for) Lynch syndrome, upper tract imaging should be performed regardless of risk category.'''
* '''For MH during pregnancy, obtain renal US with consideration of multiphasic CT or MR urography after delivery.'''
* '''For MH during pregnancy, obtain renal US with consideration of multiphasic CT or MR urography after delivery.'''